In a recent episode of The Innovators & Investors Podcast, host Kristian Marquez (Finstrat) sat down with Ranvir Mangat, co-founder and COO of InsightRX, to discuss how our platform is transforming the way medications are prescribed.
Ranvir shared the origins of InsightRX, which began with a UCSF bone marrow transplant project, and explained how we apply predictive pharmacokinetic and pharmacodynamic models (once reserved for drug development) directly to patient care. By integrating precision dosing and analytics into clinical decision-making, InsightRX helps clinicians personalize treatment plans based on each patient’s unique pharmacologic profile.
The conversation also highlighted the broader healthcare shift from fee-for-service to pay-for-performance models, where improved outcomes and cost efficiency are paramount. Ranvir spoke candidly about the challenges of working with payors, pharmacies, and hospitals in a conservative industry, and the importance of demonstrating ROI in complex healthcare ecosystems.
Listen to the full podcast to gain insight into the startup journey — from finding product-market fit to balancing rapid iteration with customer needs. Ranvir also shared how we are incorporating AI and generative technologies to enhance clinical decision support and operational efficiency, always with careful human oversight.
Finally, Ranvir reflected on the lessons learned over InsightRX’s decade-long evolution, offering practical advice on managing market hype, fundraising, and the power of strong co-founder partnerships and mentorship.
For anyone interested in healthcare innovation, precision medicine, and AI-driven clinical applications, this episode offers a compelling look at how InsightRX is shaping the future of personalized drug dosing:
